What is the latest medical insurance price of neratinib/neratinib in 2024?

Neratinib (Neratinib) is a cancer drug used to reduce the risk of recurrence in patients with early-stage breast cancer who have had surgery. It is given after treatment with trastuzumab, another drug used for the same purpose. Neratinib is only used in breast cancers that produce high levels of the HER2 protein, which helps cells divide and grow (HER2-positive breast cancer), and which also have receptors (targets) for female sex hormones (hormone receptor-positive breast cancer).

The active substance in neratinibneratinib is a type of cancer drug called a tyrosine kinase inhibitor. It attaches to the HER2 protein on cancer cells, thus blocking its effects. Because HER2 helps cancer cells grow and divide, blocking it can help stop these cells from growing and prevent the cancer from coming back.

The original drug neratinib has been launched in China and is covered by Class B medical insurance, which undoubtedly reduces the financial burden on patients. However, it is important to note that health insurance coverage is limited to patients with specific indications. In terms of market price, a box of 40mg*180 tablets of the original drug Neratinib costs about 7,000 yuan, which is still a considerable expense for families with limited financial conditions. Due to different reimbursement ratios in different regions, there may be slight differences in the price after reimbursement. Patients can consult local hospitals or medical insurance bureaus.

The price of each box of neratinib original drug marketed overseas may be more than more than 10,000 US dollars, which is even more expensive. Generic drugs of neratinib are also sold overseas. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 40mg*180 tablets produced by Bangladesh Yaopin International may be around RMB 2,000 per box (the price may fluctuate due to the exchange rate), and the price is relatively cheap.